ALK fusion promotes metabolic reprogramming of cancer cells by transcriptionally upregulating PFKFB3
Mengnan Hu, Ruoxuan Bao, Miao Lin, Xiaoran Han, Yingjie Ai, Yun Gao, Kun‐Liang Guan, Yue Xiong, Hai‐Xin Yuan
Topics & Concepts
Anaplastic lymphoma kinaseBiologyCancer researchALK inhibitorCarcinogenesisCancer cellAnaplastic large-cell lymphomaReceptor tyrosine kinaseTyrosine kinaseKinaseTranscription factorCancerLymphomaLung cancerSignal transductionCell biologyGeneticsImmunologyGeneInternal medicineMedicineMalignant pleural effusionCancer, Hypoxia, and MetabolismRNA modifications and cancerLung Cancer Treatments and Mutations